• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION GUIDEZILLA; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION GUIDEZILLA; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 1867
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ventricular Fibrillation (2130); Ventricular Tachycardia (2132); Heart Failure (2206); Vascular Dissection (3160)
Event Date 09/28/2018
Event Type  Injury  
Event Description
It was reported that the patient experienced vessel dissection and other complications.The target lesion was located in the right coronary artery (rca).A guidezilla guide extension catheter was selected for use.At 9:30 a.M.Of the procedure, the case started out as a chronic total occlusion (cto) in the rca with intentions of cannulating a septal artery off of the left anterior descending artery (lad) for a retrograde approach percutaneous coronary intervention (pci).There was mild disease in the lad.After more than three hours of repeat cannulation of the lad and subsequent septal arteries, the physician was able to reach the distal cap of the rca cto with added support from the guidezilla extension catheter.Then, attempts were made to pass through the cto, at which time the patient went into ventricular tachycardia and then ventricular fibrillation.Consequently, the patient was defibrillated multiple times and was eventually put on an impella left ventricular assist device.After patient was somewhat stable, an injection of the lad was performed and the physician noticed that there was a clot or dissection present in the lad.A grade f dissection was confirmed in the proximal lad to apex.Then, five synergy stents were selected to cover the dissection in the lad.The patient is currently still on the impella device and in the icu and the case concluded around 17:30.The patient had right ventricular failure from all the shocks and was transferred for extracorporeal membrane oxygenation (ecmo).The patient did well over the weekend and was weaned from ecmo.The patient was doing good.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GUIDEZILLA
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
two scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key7984762
MDR Text Key124333847
Report Number2134265-2018-62085
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123765
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 10/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number1867
Device Catalogue Number1867
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/28/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age57 YR
-
-